Fras-le S.A. (BVMF:FRAS3)

Regulus Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,448	5,474	4,539	2,566	2,989	2,171
Market Cap Growth	51.34%	20.59%	76.90%	-14.15%	37.65%	77.54%
Enterprise Value	8,762	5,491	4,587	2,666	3,769	2,881
Last Close Price	23.25	20.29	16.34	8.99	12.64	8.98
PE Ratio	18.94	14.89	12.03	12.53	14.15	11.53
Forward PE	14.99	9.78	9.78	9.78	9.78	9.78
PS Ratio	1.45	1.38	1.34	0.84	1.16	1.30
PB Ratio	2.98	2.43	2.44	1.44	2.70	2.27
P/TBV Ratio	20.84	3.35	3.54	1.99	5.01	4.96
P/FCF Ratio	13.81	-	5.01	-	21.54	11.73
P/OCF Ratio	10.24	48.02	4.38	-	12.20	9.00
PEG Ratio	-	0.68	0.68	0.68	0.68	0.68
EV/Sales Ratio	1.97	1.39	1.35	0.87	1.46	1.73
EV/EBITDA Ratio	10.50	7.68	6.59	6.19	10.74	12.85
EV/EBIT Ratio	13.08	9.26	7.62	8.01	14.43	18.88
EV/FCF Ratio	18.76	-	5.06	-	27.16	15.56
Debt / Equity Ratio	1.39	0.57	0.57	0.61	1.06	1.12
Debt / EBITDA Ratio	3.60	1.73	1.47	2.40	3.16	4.47
Debt / FCF Ratio	6.43	-	1.17	-	8.47	5.79
Asset Turnover	0.82	0.90	0.88	0.89	0.87	0.75
Inventory Turnover	2.36	2.87	2.74	2.56	2.78	2.88
Quick Ratio	1.07	1.32	1.40	1.66	0.92	1.13
Current Ratio	2.19	2.05	2.13	2.66	1.95	1.77
Return on Equity (ROE)	16.14%	18.22%	21.36%	14.10%	20.44%	21.00%
Return on Assets (ROA)	7.67%	8.45%	9.81%	6.08%	5.51%	4.28%
Return on Capital (ROIC)	9.92%	11.47%	13.03%	8.10%	7.58%	5.78%
Return on Capital Employed (ROCE)	12.80%	17.60%	21.50%	11.50%	11.60%	7.50%
Earnings Yield	5.08%	6.72%	8.31%	7.98%	7.07%	8.67%
FCF Yield	7.24%	-0.84%	19.97%	-7.30%	4.64%	8.53%
Dividend Yield	2.20%	2.56%	2.90%	2.94%	2.27%	3.06%
Payout Ratio	52.99%	44.27%	29.48%	34.23%	34.36%	7.46%
Buyback Yield / Dilution	-	-	-5.81%	-17.61%	-	-
Total Shareholder Return	2.20%	2.56%	-2.91%	-14.67%	2.27%	3.06%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.